United States · 
What does Sprout Group invest in?
Sprout Group invests most often at Series B and Venture (51% of the rounds on record), in sectors such as Enterprise Software, Internet and Venture Capital & Private Equity.
Sprout Group highlights
- 01
46 rounds on record
- 02
Mostly Series B and Venture: 51% of its rounds
- 03
Sole investor in 2 rounds, median $8.8M
- 04
13 exits from the portfolio
What they do
- Type
- Growth equity (from a list, unverified)
- Cheque size
- Not stated
- Sectors
- Enterprise SoftwareInternetVenture Capital & Private Equity
- Based in
- New York, United States
- Cold pitches
- Not accepted
A website was listed for this organisation, but we could not confirm it belongs to the firm that wrote these cheques. Either the site never mentions them, or it turned out to be a different company sharing the name. We show neither it nor anything read from it. Tell us the right one.
The record
Every round we can evidence, newest first46 appearances
- 2012
1 round
- Jul
- 2011
1 round
- Jan
- 2010
2 rounds
- Sept
- Apr
- 2009
3 rounds
- Sept
- Aug
- Aug
- 2007
4 rounds
- Oct
- Sept
- Aug
- May
- 2006
4 rounds
- Nov
- Oct
- Jun
- Jan
- 2005
4 rounds
- Oct
- Sept
- Aug
- Apr
- 2004
8 rounds
- Dec
- Dec
- Nov
- Sept
- Aug
- Apr
- Mar
- Jan
- 2003
8 rounds
- Nov
- Sept
- Aug
- May
- Apr
- Mar
- Jan
- Jan
- 2002
3 rounds
- Sept
- Aug
- Jan
- 2001
4 rounds
- Oct
- Jun
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Exits from the portfolio
Companies it backed that were later bought or listed13 in all
Auxilium PharmaceuticalsBought by Endo Health Solutions$2.6BOct 2014
CyOpticsBought by Avago TechnologiesUndisclosedApr 2013
EpocratesBought by AthenahealthUndisclosedJan 2013
EpocratesListedUndisclosedFeb 2011
TradeBeamBought by CDC SoftwareUndisclosedMay 2010
Phase ForwardBought by Oracle Corporation$685MApr 2010
CalixListedUndisclosedMar 2010
Lefthand NetworksBought by Hewlett-Packard$360MOct 2008
Auxilium PharmaceuticalsListedUndisclosedDec 2007
Aspreva Pharmaceuticals CorpBought by Galenica Ltd.UndisclosedOct 2007
Infinera CorporationListedUndisclosedJun 2007
Sirna TherapeuticsBought by Merck & Co.$1.1BOct 2006
Atesto TechnologiesBought by InfoVistaUndisclosedJul 2003
An exit counts when it came after the firm's first round in the company. From historical deal records.